![Anti-BCA-225 antibody [Cu-18] (STJ16100310)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/124x110/products/149028/346635/STJ16100310_1__63899.1681998708.jpg?c=1 "Anti-BCA-225 antibody [Cu-18] (STJ16100310)")
![Anti-BCA-225 antibody [Cu-18] (STJ16100310)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/1280x1280/products/149028/346635/STJ16100310_1__63899.1681998708.jpg?c=1 "Anti-BCA-225 antibody [Cu-18] (STJ16100310)")
| Host: | Mouse |
| Applications: | IHC-P |
| Reactivity: | Human |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Mouse monoclonal antibody anti-BCA-225 is suitable for use in Immunohistochemistry research applications. |
| Clonality : | Monoclonal |
| Clone ID : | Cu-18 |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Formulation: | Tris Buffer, pH 7.3-7.7, containing 1% BSA and <0.1% Sodium Azide |
| Dilution Range: | IHC 1:25-1:100 |
| Storage Instruction: | Store at 2-8°C upon receipt. |
| Background | The antibody recognizes a human breast carcinoma associated glycoprotein BCA-225 (220-225kD). This protein differs in size and distribution from other breast carcinoma antigens. Anti-BCA-225 primary antibody labels breast cancer antigen 225 (BCA-225) in primary and metastatic breast carcinoma. BCA-225 was first identified in T47D breast carcinoma cells, but its expression in other carcinomas such as lung, kidney, ovary and endometrium has |
Information sourced from Uniprot.org